CW August 2004

category image Volume 13
Issue Number 8
August 2004
ISSN 10593802

Non-Invasive Assessment of Targeted Drug Action

Positron emission tomography allows researchers to follow drug interaction that lead to the degradation of drug target.
Go to Previous Page
Go to Next Page

Source & Additional Reading

See the article on A Novel HSP90 Inhibitor Enters Phase I Study.
Nature Biotechnology, June 1, 2004.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW August 2004

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login